Informações:
Sinopse
The MDS Podcast channel was created with the ultimate goal of improving education in Parkinson's disease and other movement disorders, while keeping MDS members, other neurologists, health professionals and neuroscientists updated with novel and clinically-relevant research findings. A monthly issue of the podcast will highlight the results of an article published in the Society journals, Movement Disorders or Movement Disorders Clinical Practice, including an interview with one of the authors of the article selected.
Episódios
-
Swim for Parkinson: swimming together to improve together
18/10/2021 Duração: 09minThe neurologists Dr. Francesca Morgante and Dr. Nicola Modugno and Cecilia Ferrari, a person with Parkinson's disease, share their experience swimming across the strait of Messina, highlighting the importance of physical activity in PD.
-
Perampanel may reduce alpha-synuclein transmission in Parkinson's disease. A possible therapeutic target?Â
18/10/2021 Duração: 14minDr. Matarazzo speaks with Prof. Takahashi about the results of his recent study that shows how this anti-epileptic drug may inhibit the transmission of alpha synuclein in PD. While this was tested in animal models, future clinical trials are warranted to test the effects on PD progression.
-
Variability of Movement Disorders: The Influence of Sensation, Action, Cognition, and Emotions
18/10/2021 Duração: 15minDr. Matarazzo speaks with Prof. Maja Kojović about the paper awarded as 2021 best review article from the Movement Disorders Journal, highlighting the impact on several factors on the variability of movement disorders.
-
An interview with Claudia Trenkwalder, MDS President
30/09/2021 Duração: 14minDr. Schaefer discusses with Dr. Trenkwalder the 2021 Virtual MDS Congress, her tenure as the MDS president, and her hopes for the future of the MDS.
-
Blinded RT-QuIC analysis of alpha-synuclein biomarker in skin tissue from Parkinson's disease patients
01/09/2021 Duração: 14minDr. Schaefer speaks with Dr. Kanthasamy about RT-QuIC from skin tissues as a potential new biomarker for Parkinson's disease.
-
TikTok Tics
01/08/2021 Duração: 21minDr. Schaefer speaks with Dr. Olvera about trending videos of tics and other neurological syndromes on social media.
-
Cognitive and visuospatial abilities in dystonia
01/06/2021 Duração: 17minDr. Schaefer speaks with Dr. Camargo about the non-motor and prodromal features of dystonia.
-
Autophagy in Levodopa-Induced Dyskinesia. A new potential therapeutic target
01/05/2021 Duração: 15minDr. Matarazzo interviews Prof. Fisone about the role of autophagy in Levodopa-Induced Dyskinesia.
-
Electroconvulsive therapy in movement disorders
01/04/2021 Duração: 17minDr. Schaefer discusses with Dr. Garcia Ruiz his recent paper in Movement Disorders Clinical Practice discussing the history and data behind the use of electroconvulsive therapy in Parkinson's disease and other movement disorders.
-
Acetylcholine Nuclei Atrophy Predicts Gait Changes in Parkinson's Disease
01/03/2021 Duração: 13minDr. Matarazzo interviews Dr. Ray on a recently published article that demonstrates a relationship between changes in cholinergic nuclei in MRI and future gait disorders in Parkinson's disease.
-
Anxiety in Parkinson's disease and its correlates in MRI-based functional connectivity
01/02/2021 Duração: 09minDr. Matarazzo interviews Dr. De Micco on the functional MRI correlates of anxiety in Parkinson's disease, highlighting the main results of the article she recently published on the topic in the Movement Disorders Journal.
-
Parkinsonian syndromes and Parkinson's subtypes: Will a single neuroimaging modality ever be enough?
01/02/2021 Duração: 18minDr. Schaefer speaks with Dr. Pavese about the imaging modalities currently in use and emerging to differentiate parkinsonian syndromes and Parkinson's subtypes, and how imaging helps us to understand, study, and treat these conditions.
-
Scar Dancing Syndrome
01/01/2021 Duração: 08minDr. Wu discusses a newly-described peripherally-induced movement disorder (PIMD), and discusses with Dr. Schaefer the potential pathophysiologies of PIMDs.
-
Neuroinflammation in Parkinson's Disease, where are we now?
01/01/2021 Duração: 08minDr. Matarazzo interviews Dr. Standaert about the review article he recently published on neuroinflammation in Parkinson's disease, including the main evidence of its role on the pathogenesis of the disease and how understanding it better may help us discovering new therapeutic targets.
-
Neurofilament light chain in Parkinson's disease
20/11/2020 Duração: 11minDr. Brit Mollenhauer discusses the recent advances in the use of neurofilament light chain for the diagnosis and follow up of Parkinson's disease and related disorders, highlighting the results of a recent longitudinal study.
-
Anti-inflammatory drugs use impacts the risk of developing PD in LRRK2 mutation carriers
09/11/2020Dr. Marta San Luciano shares the main findings of the recently published article on the impact of non-steroidal anti-inflammatory drugs use on the risk of developing PD in a large LRRK2 mutation carriers cohort. Read the article
-
The impact of COVID-19 on scientific research activities
06/11/2020In this interview, Prof. Brit Mollenhauer provides insight into how researchers have been coping with the COVID-19 pandemic. Read the article
-
Value of invivosynuclein deposits in Parkinson's disease - Asystematic review and metaanalysis
14/10/2020Dr. Michele Matarazzo interviews Dr. Kazuto Tsukita, the first author of the article awarded as "2020 Review Article from Movement Disorders" on the advances of in-vivo alpha-synuclein detection as a biomarker for Parkinson. Read the article
-
Randomized controlled trial of exercise on objective and subjective sleep in Parkinson's disease
14/10/2020Dr. Michele Matarazzo interviews Dr. Amy Amara, the first author of the article awarded as "2020 Research Article from Movement Disorders" on the effects of exercise on sleep in Parkinson's disease. Read the article
-
Deep Brain Stimulation for Parkinson, beyond motor improvement: Social and Occupational outcomes
22/09/2020In this interview, Prof. Deuschl highlights the main results of the EARLYSTIM project, focusing on non-motor outcomes, and especially on the effects of DBS on Social and Occupational Functioning in Parkinson's Disease.